EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSMAG00000016513
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11

Ensembl ID : ENSSMAG00000017634
Gene Symbol: LOC118288989
2 Cross references
207 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSSMAG00000003880
Gene Symbol: LOC118291696
2 Cross references
226 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase A

Ensembl ID : ENSSMAG00000017306
Gene Symbol: HMGCRA
2 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSSMAG00000010211
Gene Symbol: HMGCRB
1 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSSMAG00000012584
Gene Symbol: PDPK1B
1 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSSMAG00000004390
Gene Symbol: HPDB
2 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSSMAG00000026760
Gene Symbol: LOC118292350
2 Cross references
276 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSSMAG00000026164
Gene Symbol: LOC118308917
2 Cross references
405 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSSMAG00000009079
Gene Symbol: NT5E
1 Cross references
215 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2a, Genome Duplicate A

Ensembl ID : ENSSMAG00000010311
Gene Symbol: HTR2AA
2 Cross references
217 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSSMAG00000001733
Gene Symbol: HTR2B
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).